Literature DB >> 28486620

What is special about 200 kDa hyaluronan that activates hyaluronan receptor signaling?

Paul H Weigel1, Bruce A Baggenstoss1.   

Abstract

The polydispersity of hyaluronan (HA) presents challenges for analyzing its solution properties, such as the relationship between mass and particle size. The broad mass range of natural HA (≤50-fold) makes molecular characterization difficult and ambiguous compared to molecules with known molecular weights (e.g., proteins). Biophysical studies show that large >MDa HA behaves like a random coil, whereas very small (e.g., 10 kDa) HA behaves like a rod. However, the mass range for this conformational transition is not easily determined in natural polydisperse HA. Some HA receptors (e.g., CD44 and HARE) initiate signaling responses upon binding HA in the 100-300 kDa range, but not larger MDa HA. Size-dependent responses are studied using nonnatural HA: purified narrow-size range HA [Pandey MS, Baggenstoss BA, Washburn J, Harris EN, Weigel PH. 2013. The hyaluronan receptor for endocytosis (HARE) activates NF-κB-mediated gene expression in response to 40-400 kDa, but not smaller or sarger, hyaluronans. J Biol Chem. 288:14068-14079] and very narrow size range Select-HA made chemo-enzymatically [Jing W, DeAngelis PL. 2004. Synchronized chemoenzymatic synthesis of monodisperse hyaluronan polymers. J Biol Chem. 279:42345-42349]. Here, we used size exclusion chromatography and multiangle light scattering to determine the weight-average molar mass and diameter of ~60 very narrow size preparations from 29 to 1650 kDa. The ratio of HA mass to HA diameter showed a transition in the 150-250 kDa size range (~65 nm). The HA rod-to-coil transition occurs within the size range that specifically activates cell signaling by some receptors. Thus, size-specific signaling could be due to unique external receptor•HA conformation changes that enable transmembrane-mediated activation of cytoplasmic domains. Alternatively and more likely, transition-size HA may enable multiple receptors to bind the same HA, creating new internal signal-competent cytoplasmic domain complexes.
© The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  CD44; HARE/STAB2; LYVE-1; RHAMM; TLR2/4

Mesh:

Substances:

Year:  2017        PMID: 28486620      PMCID: PMC5881711          DOI: 10.1093/glycob/cwx039

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  68 in total

Review 1.  Signaling properties of hyaluronan receptors.

Authors:  Eva A Turley; Paul W Noble; Lilly Y W Bourguignon
Journal:  J Biol Chem       Date:  2001-11-20       Impact factor: 5.157

2.  Methods for measuring Class I membrane-bound hyaluronan synthase activity.

Authors:  Paul H Weigel; Amy J Padgett-McCue; Bruce A Baggenstoss
Journal:  Methods Mol Biol       Date:  2013

3.  Hyaluronan fragments act as an endogenous danger signal by engaging TLR2.

Authors:  Kara A Scheibner; Michael A Lutz; Sada Boodoo; Matthew J Fenton; Jonathan D Powell; Maureen R Horton
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

4.  Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for endocytosis (HARE).

Authors:  Edward N Harris; Svetlana V Kyosseva; Janet A Weigel; Paul H Weigel
Journal:  J Biol Chem       Date:  2006-12-04       Impact factor: 5.157

5.  Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM.

Authors:  B Yang; L Zhang; E A Turley
Journal:  J Biol Chem       Date:  1993-04-25       Impact factor: 5.157

6.  The hyaluronan receptor for endocytosis (HARE) activates NF-κB-mediated gene expression in response to 40-400-kDa, but not smaller or larger, hyaluronans.

Authors:  Madhu S Pandey; Bruce A Baggenstoss; Jennifer Washburn; Edward N Harris; Paul H Weigel
Journal:  J Biol Chem       Date:  2013-03-24       Impact factor: 5.157

7.  Hyaluronic acid: molecular conformation and interactions in the tetragonal form of the potassium salt containing extended chains.

Authors:  A K Mitra; S Arnott; J K Sheehan
Journal:  J Mol Biol       Date:  1983-10-05       Impact factor: 5.469

8.  Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses.

Authors:  Mark Slevin; Shant Kumar; John Gaffney
Journal:  J Biol Chem       Date:  2002-08-22       Impact factor: 5.157

9.  Endotoxin free hyaluronan and hyaluronan fragments do not stimulate TNF-α, interleukin-12 or upregulate co-stimulatory molecules in dendritic cells or macrophages.

Authors:  Yifei Dong; Arif Arif; Mia Olsson; Valbona Cali; Blair Hardman; Manisha Dosanjh; Mark Lauer; Ronald J Midura; Vincent C Hascall; Kelly L Brown; Pauline Johnson
Journal:  Sci Rep       Date:  2016-11-21       Impact factor: 4.379

10.  Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein.

Authors:  B Yang; B L Yang; R C Savani; E A Turley
Journal:  EMBO J       Date:  1994-01-15       Impact factor: 11.598

View more
  17 in total

Review 1.  Planning, evaluating and vetting receptor signaling studies to assess hyaluronan size-dependence and specificity.

Authors:  Paul H Weigel
Journal:  Glycobiology       Date:  2017-09-01       Impact factor: 4.313

2.  Development of the LYVE-1 gene with an acidic-amino-acid-rich (AAAR) domain in evolution is associated with acquisition of lymph nodes and efficient adaptive immunity.

Authors:  Shuan Shian Huang; Ya-Wen Li; Jen-Leih Wu; Frank E Johnson; Jung San Huang
Journal:  J Cell Physiol       Date:  2017-10-04       Impact factor: 6.384

3.  A TLR/AKT/FoxO3 immune tolerance-like pathway disrupts the repair capacity of oligodendrocyte progenitors.

Authors:  Taasin Srivastava; Parham Diba; Justin M Dean; Fatima Banine; Daniel Shaver; Matthew Hagen; Xi Gong; Weiping Su; Ben Emery; Daniel L Marks; Edward N Harris; Bruce Baggenstoss; Paul H Weigel; Larry S Sherman; Stephen A Back
Journal:  J Clin Invest       Date:  2018-04-16       Impact factor: 14.808

Review 4.  Matters of size: Roles of hyaluronan in CNS aging and disease.

Authors:  Frances Tolibzoda Zakusilo; M Kerry O'Banion; Harris A Gelbard; Andrei Seluanov; Vera Gorbunova
Journal:  Ageing Res Rev       Date:  2021-10-09       Impact factor: 10.895

Review 5.  Hyaluronan and Its Interactions With Immune Cells in the Healthy and Inflamed Lung.

Authors:  Pauline Johnson; Arif A Arif; Sally S M Lee-Sayer; Yifei Dong
Journal:  Front Immunol       Date:  2018-11-29       Impact factor: 7.561

Review 6.  Differing Roles of Hyaluronan Molecular Weight on Cancer Cell Behavior and Chemotherapy Resistance.

Authors:  Zoe K Price; Noor A Lokman; Carmela Ricciardelli
Journal:  Cancers (Basel)       Date:  2018-12-03       Impact factor: 6.639

Review 7.  Role of the Hyaluronan Receptor, Stabilin-2/HARE, in Health and Disease.

Authors:  Edward N Harris; Erika Baker
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

8.  A modified flavonoid accelerates oligodendrocyte maturation and functional remyelination.

Authors:  Weiping Su; Steven Matsumoto; Fatima Banine; Taasin Srivastava; Justin Dean; Scott Foster; Peter Pham; Brian Hammond; Alec Peters; Kesturu S Girish; Kanchugarakoppal S Rangappa; Joachim Jose; Jon D Hennebold; Melinda J Murphy; Jill Bennett-Toomey; Stephen A Back; Larry S Sherman
Journal:  Glia       Date:  2019-09-06       Impact factor: 7.452

Review 9.  Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression.

Authors:  James B McCarthy; Dorraya El-Ashry; Eva A Turley
Journal:  Front Cell Dev Biol       Date:  2018-05-08

Review 10.  Ligand Binding and Signaling of HARE/Stabilin-2.

Authors:  Edward N Harris; Fatima Cabral
Journal:  Biomolecules       Date:  2019-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.